M. Gunay Et Al. , "Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity," ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.78, no.5, pp.300-304, 2015
Gunay, M. Et Al. 2015. Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.78, no.5 , 300-304.
Gunay, M., ÇELİK, G., Gunay, B. O., AKTAŞ, A., KARATEKİN, G., & Ovali, F., (2015). Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.78, no.5, 300-304.
Gunay, MURAT Et Al. "Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity," ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.78, no.5, 300-304, 2015
Gunay, MURAT Et Al. "Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity." ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.78, no.5, pp.300-304, 2015
Gunay, M. Et Al. (2015) . "Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity." ARQUIVOS BRASILEIROS DE OFTALMOLOGIA , vol.78, no.5, pp.300-304.
@article{article, author={MURAT GÜNAY Et Al. }, title={Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity}, journal={ARQUIVOS BRASILEIROS DE OFTALMOLOGIA}, year=2015, pages={300-304} }